Related Experiment Video
Updated: Aug 17, 2026

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
Implication of cyclin-dependent kinase 5 in the development of psychological dependence on and behavioral
Minoru Narita1, Masahiro Shibasaki, Yasuyuki Nagumo
1Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa-ku, Tokyo, Japan. narita@hoshi.ac.jp
Abstract:
In the present study, we investigated the role of cyclin-dependent kinase 5 (cdk5) in the brain dynamics changed by repeated in vivo treatment with morphine. The level of phosphorylated-cdk5 was significantly increased in the cingulate cortex of mice showing the morphine-induced rewarding effect. Under these conditions, roscovitine, a cdk5 inhibitor, given intracerebroventricularly (i.c.v.) caused a dose-dependent and significant inhibition of the morphine-induced rewarding effect. In addition, the dose-response effect of the morphine-induced rewarding effect was dramatically attenuated in cdk5 heterozygous (+/-) knockout mice. Furthermore, the development of behavioral sensitization by intermittent administration of morphine was virtually abolished in cdk5 (+/-) mice. These findings suggest that the induction and/or activation of cdk5 are implicated in the development of psychological dependence on morphine.
Insights
Cyclin-dependent kinase 5 (cdk5) plays a key role in morphine
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Repeated morphine administration alters brain dynamics.
- Understanding the molecular mechanisms underlying morphine dependence is crucial.
Purpose of the Study:
- To investigate the role of cyclin-dependent kinase 5 (cdk5) in morphine-induced brain changes and dependence.
- To determine if cdk5 inhibition or deficiency affects morphine's rewarding effects and behavioral sensitization.
Main Methods:
- In vivo repeated morphine treatment in mice.
- Measurement of phosphorylated-cdk5 levels in the cingulate cortex.
- Administration of roscovitine (cdk5 inhibitor) via intracerebroventricular injection.
- Assessment of morphine's rewarding effect and behavioral sensitization in wild-type and cdk5 heterozygous (+/-) knockout mice.
Main Results:
- Phosphorylated-cdk5 levels increased in the cingulate cortex following morphine treatment.
- Roscovitine dose-dependently inhibited the morphine-induced rewarding effect.
- Morphine's rewarding effect and behavioral sensitization were significantly attenuated in cdk5 (+/-) mice.
Conclusions:
- Cyclin-dependent kinase 5 (cdk5) induction and/or activation are implicated in the development of morphine dependence.
- Targeting cdk5 may offer a novel therapeutic strategy for managing opioid addiction.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Drug Dependence
Opioid Analgesics: Synthetic and Semisynthetic Opioids

